AKT PHOSPHORYLATION AT SERINE 473 IS A POWERFUL NOVEL BIOMARKER IN ACUTE MYELOID LEUKAEMIA, AND IS RELATED TO PROTEIN PHOSPHATASE 2A (PP2A) INHIBITION BY CIP2A AND SETBP1

被引：0
|
作者：
Lucas, C. [1 ]
Carmell, N. [1 ]
Scott, L. [1 ]
Holcroft, A. [1 ]
Hills, R. [2 ]
Clark, R. [1 ]
机构：
[1] Univ Liverpool, Haematol, Liverpool L69 3BX, Merseyside, England
[2] Cardiff Univ, Sch Med, Inst Translat Innovat Methodol & Engagement, Cardiff CF10 3AX, S Glam, Wales
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S796
引用
收藏
页码：317 / 317
页数：1
相关论文
共 24 条
  • [1] PP2A Inhibition By CIP2A or SETBP1 Leads to Elevated Levels of AKT S473 Which Can be Used As a Biomarker of Outcome in Acute Myeloid Leukaemia
    Hills, Robert K.
    Lucas, Claire M.
    Scott, Laura J.
    Carmell, Natasha
    Holcroft, Alison K.
    Clark, Richard E.
    BLOOD, 2015, 126 (23)
  • [2] CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
    Lucas, Claire M.
    Scott, Laura J.
    Carmell, Natasha
    Holcroft, Alison K.
    Hills, Robert K.
    Burnett, Alan K.
    Clark, Richard E.
    BLOOD ADVANCES, 2018, 2 (09) : 964 - 968
  • [3] Involvement of CIP2A, a novel human oncoprotein inhibiting protein phosphatase 2A (PP2A), in breast cancer
    Laine, A.
    Come, C.
    Junttila, M. R.
    Puustinen, P.
    Niemela, M.
    Boulfroy, M.
    Thezenas, S.
    Darbon, J. -M.
    Isola, J.
    Kallioniemi, O. -P.
    Westermarck, J.
    FEBS JOURNAL, 2008, 275 : 454 - 454
  • [4] CHEMICAL PROTEOMICS TO IDENTIFY THE MECHANISM OF PROTEIN PHOSPHATASE 2A (PP2A) INHIBITION IN ACUTE MYELOID LEUKAEMIA (AML)
    Li, Xiang
    Flanagan, Hayley
    Kahl, Richard
    Rigby, Callum
    Verrills, Nicole
    Dun, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 11 - 11
  • [5] Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer
    Birkman, Eva-Maria
    Elzagheid, Adam
    Jokilehto, Terhi
    Avoranta, Tuulia
    Korkeila, Eija
    Kulmala, Jarmo
    Syrjanen, Kari
    Westermarck, Jukka
    Sundstrom, Jari
    CANCER MEDICINE, 2018, 7 (03): : 698 - 706
  • [6] In chronic myeloid leukaemia cells, the oncoprotein CIP2A binds directly to and alters expression of many cellular proteins, independent of effects on protein phosphatase 2A (PP2A)
    Austin, J. A.
    Lucas, C. M.
    Jenkins, R. E.
    Dunn, K.
    Scott, L. J.
    Glenn, M. A.
    White, M.
    Clark, R. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 52 - 53
  • [7] Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia
    Matthew D. Dun
    Abdul Mannan
    Callum J. Rigby
    Stephen Butler
    Hamish D. Toop
    Dominik Beck
    Patrick Connerty
    Jonathan Sillar
    Richard G. S. Kahl
    Ryan J. Duchatel
    Zacary Germon
    Sam Faulkner
    Mengna Chi
    David Skerrett-Byrne
    Heather C. Murray
    Hayley Flanagan
    Juhura G. Almazi
    Hubert Hondermarck
    Brett Nixon
    Geoff De Iuliis
    Janis Chamberlain
    Frank Alvaro
    Charles E. de Bock
    Jonathan C. Morris
    Anoop K. Enjeti
    Nicole M. Verrills
    Leukemia, 2020, 34 : 3393 - 3397
  • [8] Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia
    Dun, Matthew D.
    Mannan, Abdul
    Rigby, Callum J.
    Butler, Stephen
    Toop, Hamish D.
    Beck, Dominik
    Connerty, Patrick
    Sillar, Jonathan
    Kahl, Richard G. S.
    Duchatel, Ryan J.
    Germon, Zacary
    Faulkner, Sam
    Chi, Mengna
    Skerrett-Byrne, David
    Murray, Heather C.
    Flanagan, Hayley
    Almazi, Juhura G.
    Hondermarck, Hubert
    Nixon, Brett
    De Iuliis, Geoff
    Chamberlain, Janis
    Alvaro, Frank
    de Bock, Charles E.
    Morris, Jonathan C.
    Enjeti, Anoop K.
    Verrills, Nicole M.
    LEUKEMIA, 2020, 34 (12) : 3393 - 3397
  • [9] Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibition
    Liu, Chun-Yu
    Hsieh, Feng-Shu
    Chu, Pei-Yi
    Tsai, Wen-Chun
    Huang, Chun-Teng
    Yu, Yuan-Bin
    Huang, Tzu-Ting
    Ko, Po-Shen
    Hung, Man-Hsin
    Wang, Wan-Lun
    Shiau, Chung-Wai
    Chen, Kuen-Feng
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (05) : 726 - 740
  • [10] Contribution Value of Akt, c-Myc, CIP2A, and PP2A Genes Expression in Leukemogenesis: A Bright Perspective on the Molecular Pattern of Patients with Acute Myeloid Leukemia (AML)
    Sayyadi, Mohammad
    Safaroghli-Azar, Ava
    Rabiemajd, Somayeh
    Didehdar, Mojtaba
    Abolghasemi, Hassan
    Anoushirvani, Ali Arash
    Bashash, Davood
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2020, 13 (03)
123